12-22457135-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001286176.2(C2CD5):āc.2713G>Cā(p.Val905Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000586 in 1,603,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001286176.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C2CD5 | NM_001286176.2 | c.2713G>C | p.Val905Leu | missense_variant | 25/27 | ENST00000446597.6 | NP_001273105.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD5 | ENST00000446597.6 | c.2713G>C | p.Val905Leu | missense_variant | 25/27 | 1 | NM_001286176.2 | ENSP00000388756.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000332 AC: 8AN: 241028Hom.: 0 AF XY: 0.0000614 AC XY: 8AN XY: 130318
GnomAD4 exome AF: 0.0000592 AC: 86AN: 1451510Hom.: 0 Cov.: 30 AF XY: 0.0000610 AC XY: 44AN XY: 721822
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.2560G>C (p.V854L) alteration is located in exon 23 (coding exon 22) of the C2CD5 gene. This alteration results from a G to C substitution at nucleotide position 2560, causing the valine (V) at amino acid position 854 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at